TERMINATED

NOLA (NeuWave Observational Liver Ablation) Registry

Talk to us

Conditions

Cancer of the LiverLiver CancerNeoplasms, Liver

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.

Official Title

A Multicenter Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue Lesions

Quick Facts

Study Start:2020-01-15
Study Completion:2025-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:TERMINATED

Study ID

NCT04107766

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:22 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patients who underwent or are scheduled to undergo a microwave ablation of one or more liver lesions with the NEUWAVE Microwave Ablation System per the device's Instructions for Use (IFU).
  2. 2. Patients with signed informed consent (or waiver approved by IRB/EC) who are willing to comply with the assessment schedule, and willing to have data included in the database.
  3. 3. Patients greater than or equal to 22 years old at the time of informed consent (or waiver approved by IRB/EC).
  1. 1. Patients with a life expectancy of less than 1 year, in the opinion of the treating physician.
  2. 2. Use of microwave ablation purely as a transection tool, rather than focused liver lesion ablation.
  3. 3. Patient is currently participating, or planning to participate, in another NeuWave/Ethicon-funded clinical trial or registry studying microwave ablation in the liver. Note: roll-over patients from previous NeuWave trials are permitted.

Contacts and Locations

Study Locations (Sites)

Loma Linda University Medical Center
Loma Linda, California, 92354
United States
Cedars Sinai Medical Center
Los Angeles, California, 90048
United States
David Geffen School of Medicine at UCLA
Los Angeles, California, 90095
United States
Sutter Institute for Medical Research
Sacramento, California, 95816
United States
Olive View UCLA
Sylmar, California, 91342
United States
Mayo Clinic
Jacksonville, Florida, 32224
United States
Sarasota Memorial Hospital
Sarasota, Florida, 34239
United States
ICAHN School of Medicine at Mount Sinai
New York, New York, 10029
United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
United States
MD Anderson Cancer Center
Houston, Texas, 77030
United States
University of Virginia
Charlottesville, Virginia, 22908
United States
University of Washington Medical Center
Seattle, Washington, 98101
United States
University of Wisconsin At Madison
Madison, Wisconsin, 53792
United States

Collaborators and Investigators

Sponsor: Ethicon, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-15
Study Completion Date2025-06-01

Study Record Updates

Study Start Date2020-01-15
Study Completion Date2025-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer of the Liver
  • Liver Cancer
  • Neoplasms, Liver